Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sparfloxacin for the treatment of community-acquired pneumonia: A pooled data analysis of two studies
Ist Teil von
Journal of Antimicrobial Chemotherapy [J. ANTIMICROB. CHEMOTHER.]. Vol. 37, no. A Suppl. May 1996, 1996, Vol.37, p.no. A Sul.-no. A Sul.
Erscheinungsjahr
1996
Quelle
Oxford Journals 2020 Medicine
Beschreibungen/Notizen
A pooled data analysis of two double-blind studies encompassing 1137 episodes of community-acquired pneumonia in hospitalised adults, of which 560 were treated with sparfloxacin and 577 were randomised to comparator antibacterial agents (amoxycillin/clavulanic acid, erythromycin or amoxycillin administered at reference dosages), was performed. The global efficacy rate at the end of treatment in evaluable patients treated with sparfloxacin was 88.3% compared with 84.1% in those who received comparator antibacterial agents. This analysis verified the efficacy of this new aminofluoroquinolone, given orally once daily, in the treatment of community acquired pneumonia. The overall outcome favoured sparfloxacin for use in the empirical treatment of community-acquired pneumonia.
Sprache
Englisch
Identifikatoren
ISSN: 0305-7453
eISSN: 1460-2091
Titel-ID: cdi_proquest_miscellaneous_15821592
Format
–
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von bX